Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 19;22(6):3134.
doi: 10.3390/ijms22063134.

Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases

Affiliations
Review

Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases

Camillo Ricordi et al. Int J Mol Sci. .

Abstract

COVID-19 is without any doubt the worst pandemic we have faced since the H1N1 virus outbreak. Even if vaccination against SARS-CoV-2 infection is becoming increasingly available, a more feasible approach for COVID-19 prevention and therapy is still needed. Evidence of a pathological link between metabolic diseases and severe forms of COVID-19 has stimulated critical reflection and new considerations. In particular, an abnormal immune response observed in certain patients with SARS-CoV-2 infection suggested possible common predisposing risk factors with autoimmune diseases such as Type 1 Diabetes (T1D). Correct supplementation with dietary factors may be key to preventing and counteracting both the underlying metabolic impairment and the complications of COVID-19. A set of agents may inhibit the cytokine storm and hypercoagulability that characterize severe COVID-19 infection: vitamin D3, omega-3 polyunsaturated fatty acids, polyphenols like pterostilbene, polydatin and honokiol, which can activate anti-inflammatory and antioxidant sirtuins pathways, quercetin, vitamin C, zinc, melatonin, lactoferrin and glutathione. These agents could be highly beneficial for subjects who have altered immune responses. In this review, we discuss the antiviral and metabolic effects of these dietary factors and propose their combination for potential applications in the prevention and treatment of COVID-19. Rigorous studies will be fundamental for validating preventive and therapeutic protocols that could be of assistance to mitigate disease progression following SARS-CoV-2 infection.

Keywords: COVID-19; metabolic diseases; natural supplements.

PubMed Disclaimer

Conflict of interest statement

C.R. is scientific advisor of Fondazione Barilla Center for Food and Nutrition, Zone Labs and SIRT500 Sagl.

Figures

Figure 1
Figure 1
Impact of COVID-19 on patients with diabetes. Survival rate is dramatically reduced in subjects with diabetes infected with SARS-CoV-2. Created with BioRender.com.
Figure 2
Figure 2
Proposed protective effects for melatonin and quercetin against SARS-CoV-2 infection. Melatonin and quercetin may blunt the deleterious effects of SARS-CoV-2 by reducing activation of the cytokine storm. Created with BioRender.com.

Similar articles

Cited by

References

    1. Jutzeler C.R., Bourguignon L., Weis C.V., Tong B., Wong C., Rieck B., Pargger H., Tschudin-Sutter S., Egli A., Borgwardt K., et al. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020;37:101825. doi: 10.1016/j.tmaid.2020.101825. - DOI - PMC - PubMed
    1. Chen S., Du K., Zou C. Current progress in stem cell therapy for type 1 diabetes mellitus. Stem Cell Res. Ther. 2020;11:275. doi: 10.1186/s13287-020-01793-6. - DOI - PMC - PubMed
    1. Astuti I. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. 2020;14:407–412. doi: 10.1016/j.dsx.2020.04.020. - DOI - PMC - PubMed
    1. Jaimes J.A., Millet J.K., Whittaker G.R. Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site. iScience. 2020;23:101212. doi: 10.1016/j.isci.2020.101212. - DOI - PMC - PubMed
    1. Rubino F., Amiel S.A., Zimmet P., Alberti G., Bornstein S., Eckel R.H., Mingrone G., Boehm B., Cooper M.E., Chai Z., et al. New-Onset Diabetes in Covid-19. N. Engl. J. Med. 2020;383:789–790. doi: 10.1056/NEJMc2018688. - DOI - PMC - PubMed

MeSH terms